Free Trial
→ A Simple Guide to Options Trading While It's Still Free (From True Market Insiders) (Ad)tc pixel Free ANTX Stock Alerts

Anthem (ANTX) Financials

Anthem logo
$4.40 -0.28 (-5.98%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$4.41 +0.01 (+0.23%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Anthem

Annual Income Statements for Anthem

This table shows Anthem's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -28 -43 -64 -52 -35
Consolidated Net Income / (Loss)		 -22 -41 -65 -51 -35
Net Income / (Loss) Continuing Operations		 -22 -41 -65 -51 -35
Total Pre-Tax Income 		-22 -42 -65 -51 -35
Total Operating Income		 -22 -42 -70 -57 -38
Total Gross Profit		 0.00 0.00 0.00 0.00 0.00
Total Revenue		 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 22 42 70 57 38
Selling, General & Admin Expense		 4.67 13 15 14 13
Research & Development Expense		 17 30 55 40 25
Restructuring Charge		 - - 0.00 2.23 0.00
Total Other Income / (Expense), net		 0.03 0.00 4.90 5.47 2.94
Interest & Investment Income		 0.07 - 4.86 5.47 2.93
Other Income / (Expense), net		 -0.04 - 0.04 0.00 0.00
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - - -0.65 0.24 -0.03
Basic Earnings per Share		 ($10.64) ($2.79) ($2.74) ($1.72) ($1.16)
Weighted Average Basic Shares Outstanding		 2.64M 15.34M 23.60M 29.83M 30.22M
Diluted Earnings per Share		 ($10.64) ($2.79) ($2.74) ($1.72) ($1.16)
Weighted Average Diluted Shares Outstanding		 2.64M 15.34M 23.60M 29.83M 30.22M
Weighted Average Basic & Diluted Shares Outstanding		 - 19.40M 29.77M 30.10M 35.94M

Quarterly Income Statements for Anthem

This table shows Anthem's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -16 -17 -15 -13 -7.60 -11 -6.49 -9.31 -8.72 -10 -8.20
Consolidated Net Income / (Loss)		 -17 -17 -14 -13 -7.52 -11 -6.46 -9.35 -8.71 -10 -8.19
Net Income / (Loss) Continuing Operations		 -17 -17 -14 -13 -7.52 -11 -6.46 -9.35 -8.71 -10 -8.19
Total Pre-Tax Income 		-16 -17 -14 -13 -7.52 -11 -6.46 -9.35 -8.71 -10 -8.19
Total Operating Income		 -19 -18 -16 -14 -8.60 -12 -7.22 -10 -9.32 -11 -8.90
Total Gross Profit		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Revenue		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Cost of Revenue		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Operating Expenses		 19 18 16 14 8.60 12 7.22 10 9.32 11 8.90
Selling, General & Admin Expense		 3.90 3.64 3.73 3.48 3.21 3.85 4.02 3.04 2.44 3.81 2.89
Research & Development Expense		 15 15 12 8.29 5.40 7.69 3.20 7.00 6.88 6.74 6.02
Total Other Income / (Expense), net		 2.71 1.68 1.45 1.27 1.08 0.89 0.75 0.69 0.61 0.52 0.72
Interest & Investment Income		 - 1.68 1.45 1.27 1.08 0.89 0.75 0.69 0.61 0.52 0.72
Other Income / (Expense), net		 - 0.00 0.00 0.00 - - 0.00 0.00 0.00 - -0.00
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - 0.22 0.08 -0.14 0.08 -0.02 0.02 -0.04 0.01 0.06 0.02
Basic Earnings per Share		 ($0.49) ($0.56) ($0.48) ($0.43) ($0.25) ($0.35) ($0.21) ($0.31) ($0.29) ($0.29) ($0.18)
Weighted Average Basic Shares Outstanding		 23.60M 29.76M 29.82M 29.84M 29.83M 30.05M 30.17M 30.28M 30.22M 34.06M 44.76M
Diluted Earnings per Share		 ($0.49) ($0.56) ($0.48) ($0.43) ($0.25) ($0.35) ($0.21) ($0.31) ($0.29) ($0.29) ($0.18)
Weighted Average Diluted Shares Outstanding		 23.60M 29.76M 29.82M 29.84M 29.83M 30.05M 30.17M 30.28M 30.22M 34.06M 44.76M
Weighted Average Basic & Diluted Shares Outstanding		 29.77M 29.83M 29.84M 29.88M 30.10M 30.18M 27.33M 27.40M 35.94M 36.02M 37.74M

Annual Cash Flow Statements for Anthem

This table details how cash moves in and out of Anthem's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 8.03 15 -12 5.70 -1.41
Net Cash From Operating Activities		 -20 -33 -53 -49 -30
Net Cash From Continuing Operating Activities		 -20 -33 -53 -49 -30
Net Income / (Loss) Continuing Operations		 -22 -41 -65 -51 -35
Consolidated Net Income / (Loss)		 -22 -41 -65 -51 -35
Amortization Expense		 0.05 -0.69 -2.86 -3.28 -1.07
Non-Cash Adjustments To Reconcile Net Income		 0.97 4.39 8.47 8.34 6.25
Changes in Operating Assets and Liabilities, net		 0.03 3.80 5.83 -3.00 0.16
Net Cash From Investing Activities		 -50 -22 -43 55 28
Net Cash From Continuing Investing Activities		 -50 -22 -43 55 28
Purchase of Investments		 -77 -94 -132 -47 -46
Sale and/or Maturity of Investments		 27 72 89 101 75
Net Cash From Financing Activities		 79 70 85 0.37 0.11
Net Cash From Continuing Financing Activities		 79 70 85 0.37 0.11
Issuance of Common Equity		 0.00 70 85 0.15 0.09
Other Financing Activities, net		 0.01 0.00 0.10 0.23 0.03

Quarterly Cash Flow Statements for Anthem

This table details how cash moves in and out of Anthem's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -17 9.05 2.08 6.74 -12 -1.37 -1.77 -0.22 1.94 34 -9.17
Net Cash From Operating Activities		 -17 -18 -14 -12 -5.27 -11 -7.60 -6.38 -5.24 -12 -7.00
Net Cash From Continuing Operating Activities		 -17 -18 -14 -12 -5.27 -11 -7.60 -6.38 -5.24 -12 -7.00
Net Income / (Loss) Continuing Operations		 -17 -17 -14 -13 -7.52 -11 -6.46 -9.35 -8.71 -10 -8.19
Consolidated Net Income / (Loss)		 -17 -17 -14 -13 -7.52 -11 -6.46 -9.35 -8.71 -10 -8.19
Amortization Expense		 -1.31 -1.09 -0.89 -0.73 -0.57 -0.44 -0.30 -0.21 -0.12 -0.08 -0.09
Non-Cash Adjustments To Reconcile Net Income		 2.29 2.39 2.27 1.90 1.78 2.05 2.00 0.80 1.40 1.46 0.97
Changes in Operating Assets and Liabilities, net		 -1.15 -2.27 -1.33 -0.43 1.04 -1.58 -2.84 2.39 2.19 -3.42 0.31
Net Cash From Investing Activities		 0.42 26 16 19 -6.88 9.19 5.83 6.11 7.17 8.29 -3.66
Net Cash From Continuing Investing Activities		 0.42 26 16 19 -6.88 9.19 5.83 6.11 7.17 8.29 -3.66
Purchase of Investments		 -20 0.00 -13 -9.78 -24 -22 -12 -3.89 -8.33 -2.70 -14
Sale and/or Maturity of Investments		 20 26 29 29 18 32 18 10 16 11 10
Net Cash From Financing Activities		 -0.32 0.35 - 0.02 - 0.07 - 0.05 - 37 1.49
Net Cash From Continuing Financing Activities		 -0.32 0.35 - 0.02 - 0.07 - 0.05 - 37 1.49
Issuance of Common Equity		 -0.32 0.12 - 0.02 - 0.04 - 0.05 - 37 -14
Other Financing Activities, net		 - 0.23 - - - 0.03 - - - 0.02 15

Annual Balance Sheets for Anthem

This table presents Anthem's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 65 103 139 92 62
Total Current Assets		 60 99 111 86 60
Cash & Equivalents		 12 27 16 21 20
Short-Term Investments		 46 69 92 62 38
Prepaid Expenses		 1.55 2.51 3.21 2.64 1.94
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 5.21 3.94 28 5.83 2.01
Long-Term Investments		 3.49 3.22 27 5.02 2.01
Other Noncurrent Operating Assets		 1.72 0.72 1.04 0.80 0.00
Total Liabilities & Shareholders' Equity		 65 103 139 92 62
Total Liabilities		 3.41 7.19 14 10 8.89
Total Current Liabilities		 3.40 7.19 0.00 10 8.72
Accounts Payable		 1.06 2.12 2.68 3.32 3.02
Accrued Expenses		 1.40 2.84 6.68 4.45 2.05
Current Employee Benefit Liabilities		 0.92 2.17 4.02 1.68 2.42
Other Current Liabilities		 0.02 0.06 0.67 0.79 1.23
Total Noncurrent Liabilities		 0.01 0.00 0.00 0.00 0.17
Other Noncurrent Operating Liabilities		 0.01 0.00 0.00 0.00 0.17
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -47 95 125 82 53
Total Preferred & Common Equity		 -47 95 125 82 53
Preferred Stock		 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 -47 95 125 82 53
Common Stock		 0.00 185 279 288 294
Retained Earnings		 -47 -90 -154 -206 -241
Accumulated Other Comprehensive Income / (Loss)		 -0.03 -0.37 0.28 0.03 0.06

Quarterly Balance Sheets for Anthem

This table presents Anthem's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 154 121 108 98 81 76 67 87 82
Total Current Assets		 126 116 107 98 70 68 64 87 80
Cash & Equivalents		 33 25 27 34 20 18 18 53 44
Short-Term Investments		 91 90 78 60 47 45 44 32 34
Prepaid Expenses		 2.59 2.10 2.90 4.26 2.50 4.61 2.10 2.20 1.60
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 27 4.95 1.04 0.00 12 8.30 3.22 0.00 1.69
Long-Term Investments		 26 3.90 0.00 0.00 11 8.30 3.22 0.00 1.47
Other Noncurrent Operating Assets		 1.04 1.04 1.04 0.00 0.30 0.00 0.00 - 0.22
Total Liabilities & Shareholders' Equity		 154 121 108 98 81 76 67 87 82
Total Liabilities		 15 11 10 10 8.01 6.98 6.86 5.73 5.76
Total Current Liabilities		 15 11 10 10 8.01 6.98 6.86 5.56 5.59
Accounts Payable		 4.88 2.43 1.89 1.71 3.07 2.11 2.23 2.62 1.97
Accrued Expenses		 6.79 6.91 5.84 4.92 4.04 2.95 2.71 1.77 1.75
Current Employee Benefit Liabilities		 2.20 1.00 1.84 2.11 0.53 1.20 1.74 0.61 1.10
Other Current Liabilities		 0.98 0.32 0.56 1.28 0.37 0.72 0.18 0.57 0.78
Total Noncurrent Liabilities		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.17 0.17
Other Noncurrent Operating Liabilities		 0.00 - - - - - - 0.17 0.17
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 139 111 98 88 73 69 60 82 76
Total Preferred & Common Equity		 139 111 98 88 73 69 60 82 76
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 139 111 98 88 73 69 60 82 76
Common Stock		 277 282 284 286 290 292 293 333 335
Retained Earnings		 -138 -171 -186 -198 -216 -223 -232 -251 -259
Accumulated Other Comprehensive Income / (Loss)		 -0.12 0.05 -0.03 0.11 0.05 0.03 0.06 -0.01 -0.02

Annual Metrics And Ratios for Anthem

This table displays calculated financial ratios and metrics derived from Anthem's official financial filings.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 19,402,658.00 29,741,445.00 29,878,890.00 27,402,024.00
DEI Adjusted Shares Outstanding		 0.00 19,402,658.00 29,741,445.00 29,878,890.00 27,402,024.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 -2.20 -2.15 -1.73 -1.28
Growth Metrics		 - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 0.00% -99.24% -68.66% 17.09% 34.78%
EBIT Growth		 0.00% -95.55% -64.67% 18.40% 32.89%
NOPAT Growth		 0.00% -95.89% -64.77% 18.45% 32.89%
Net Income Growth		 0.00% -90.11% -58.05% 20.72% 31.46%
EPS Growth		 0.00% 73.78% 1.79% 37.23% 32.56%
Operating Cash Flow Growth		 0.00% -63.36% -59.25% 7.56% 39.43%
Free Cash Flow Firm Growth		 0.00% 0.00% -66.07% 0.26% 37.98%
Invested Capital Growth		 0.00% -2,836.84% -150.59% 30.63% -2.42%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% -16.15% -11.08% 15.43% -0.68%
EBIT Q/Q Growth		 0.00% -15.20% -9.95% 15.25% -1.91%
NOPAT Q/Q Growth		 0.00% -13.06% -10.01% 15.25% -1.92%
Net Income Q/Q Growth		 0.00% -11.72% -8.47% 15.45% -3.50%
EPS Q/Q Growth		 0.00% 63.77% -191.49% 12.24% -3.57%
Operating Cash Flow Q/Q Growth		 0.00% 3.89% -21.50% 19.32% 0.12%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% -26.43% 18.35% 2.40%
Invested Capital Q/Q Growth		 0.00% -387.64% 12.65% -18.00% -46.00%
Profitability Metrics		 - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.00% 96.91% 100.00% 100.00% 100.00%
Interest Burden Percent		 99.68% 100.00% 93.02% 90.37% 92.30%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -34.80% -52.08% -58.83% -49.69% -52.14%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 26.65% -15.88% -58.83% -49.69% -52.14%
Return on Equity Simple (ROE_SIMPLE)		 45.44% -42.94% -51.91% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -15 -30 -49 -40 -27
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -10.38% -14.10% -13.68% -10.37% -11.43%
Return On Investment Capital (ROIC_SIMPLE)		 - - -39.09% -48.57% -50.28%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -22 -42 -70 -57 -38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -22 -43 -72 -60 -39
Valuation Ratios		 - - - - -
Price to Book Value (P/BV)		 0.00 1.94 4.89 0.50 0.59
Price to Tangible Book Value (P/TBV)		 0.00 1.94 4.89 0.50 0.59
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.00 -1.03 -1.06 -1.08 -1.10
Leverage Ratio		 1.06 1.07 1.10 1.12 1.14
Compound Leverage Factor		 1.05 1.07 1.02 1.01 1.05
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 176.58% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 -76.58% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 11.08 13.92 23.78 -1.76 -4.37
Noncontrolling Interest Sharing Ratio		 176.58% 69.51% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - -
Current Ratio		 17.70 13.72 0.00 8.43 6.87
Quick Ratio		 17.25 13.37 0.00 8.17 6.65
Cash Flow Metrics		 - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -26 -43 -43 -27
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - -
Invested Capital		 -0.13 -3.91 -9.79 -6.79 -6.95
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 0.00 -3.77 -5.88 3.00 -0.16
Enterprise Value (EV)		 116 86 475 -47 -29
Market Capitalization		 69 185 609 41 31
Book Value per Share		 ($17.97) $4.92 $4.19 $2.74 $1.94
Tangible Book Value per Share		 ($17.97) $4.92 $4.19 $2.74 $1.94
Total Capital		 62 95 125 82 53
Total Debt		 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00
Net Debt		 -62 -99 -134 -89 -60
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -1.84 -4.62 3.21 -7.59 -6.78
Debt-free Net Working Capital (DFNWC)		 57 91 111 76 51
Net Working Capital (NWC)		 57 91 111 76 51
Net Nonoperating Expense (NNE)		 6.44 11 16 12 8.50
Net Nonoperating Obligations (NNO)		 -62 -99 -134 -89 -60
Total Depreciation and Amortization (D&A)		 0.05 -0.69 -2.86 -3.28 -1.07
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($2.79) ($2.74) ($1.72) ($1.16)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 15.34M 23.60M 29.83M 30.22M
Adjusted Diluted Earnings per Share		 $0.00 ($2.79) ($2.74) ($1.72) ($1.16)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 15.34M 23.60M 29.83M 30.22M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 19.40M 29.77M 30.10M 35.94M
Normalized Net Operating Profit after Tax (NOPAT)		 -15 -30 -49 -38 -27
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -5.62% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Anthem

This table displays calculated financial ratios and metrics derived from Anthem's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 29,741,445.00 29,770,375.00 29,829,040.00 29,842,431.00 29,878,890.00 30,098,720.00 30,175,720.00 27,326,165.00 27,402,024.00 35,941,195.00 36,016,161.00
DEI Adjusted Shares Outstanding		 29,741,445.00 29,770,375.00 29,829,040.00 29,842,431.00 29,878,890.00 30,098,720.00 30,175,720.00 27,326,165.00 27,402,024.00 35,941,195.00 36,016,161.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.55 -0.57 -0.49 -0.42 -0.25 -0.35 -0.21 -0.34 -0.32 -0.28 -0.23
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 -56.57% -23.02% 1.71% 15.06% 54.45% 38.20% 55.19% 30.48% -2.91% 11.25% -19.75%
EBIT Growth		 -50.81% -19.40% 4.34% 16.12% 54.30% 36.94% 54.56% 28.36% -8.34% 8.55% -23.41%
NOPAT Growth		 -50.81% -14.07% 4.34% 22.92% 54.30% 36.94% 54.56% 28.36% -8.35% 8.55% -23.39%
Net Income Growth		 -42.70% -8.44% 8.66% 23.70% 55.49% 35.92% 55.23% 26.63% -15.79% 5.83% -26.66%
EPS Growth		 -137.40% 29.11% 40.74% 33.85% 48.98% 37.50% 56.25% 27.91% -16.00% 17.14% 14.29%
Operating Cash Flow Growth		 -123.46% -51.72% -12.16% -1.75% 69.11% 39.61% 47.17% 46.91% 0.70% -13.64% 7.91%
Free Cash Flow Firm Growth		 -46.94% -38.11% -205.13% -557.23% -23.71% 8.03% 28.67% 47.45% 29.49% 12.66% 47.27%
Invested Capital Growth		 -150.59% -25.33% 17.45% 48.65% 30.63% 30.68% 61.61% 17.22% -2.42% 32.28% -65.68%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 -15.90% 3.65% 13.49% 12.08% 37.84% -30.71% 37.27% -36.41% 7.99% -12.72% 15.36%
EBIT Q/Q Growth		 -12.62% 2.76% 13.20% 11.75% 38.65% -34.18% 37.45% -39.14% 7.22% -13.27% 15.60%
NOPAT Q/Q Growth		 -3.49% 2.76% 13.21% 11.75% 38.65% -34.18% 37.45% -39.14% 7.21% -13.26% 15.61%
Net Income Q/Q Growth		 -1.14% 1.66% 13.13% 11.69% 40.99% -41.57% 39.32% -44.74% 6.87% -15.13% 18.38%
EPS Q/Q Growth		 24.62% -14.29% 14.29% 10.42% 41.86% -40.00% 40.00% -47.62% 6.45% 0.00% 37.93%
Operating Cash Flow Q/Q Growth		 -44.64% -3.08% 18.24% 16.53% 56.08% -101.48% 28.47% 16.11% 17.87% -130.58% 42.04%
Free Cash Flow Firm Q/Q Growth		 -213.89% -54.88% -10.06% -22.83% 40.92% -15.14% 14.64% 9.51% 20.72% -42.64% 48.47%
Invested Capital Q/Q Growth		 12.65% 23.20% 17.71% 6.98% -18.00% 23.25% 54.42% -100.55% -46.00% 49.25% -11.50%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 104.95% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 85.58% 90.83% 90.90% 90.96% 87.49% 92.30% 89.55% 93.16% 93.51% 95.04% 91.91%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -58.83% -68.38% -69.48% -53.56% -49.69% -49.32% -44.71% -45.91% -52.14% -44.56% -50.12%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 -58.83% -68.38% -69.48% -53.56% -49.69% -49.32% -44.71% -45.91% -52.14% -44.56% -50.12%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -59.70% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -13 -13 -11 -9.81 -6.02 -8.08 -5.05 -7.03 -6.52 -7.39 -6.23
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -3.19% -3.69% -3.32% -2.41% -1.35% -2.62% -1.61% -2.93% -2.94% -3.23% -2.58%
Return On Investment Capital (ROIC_SIMPLE)		 -10.56% -11.58% -11.30% -11.19% -7.35% -11.01% -7.34% -11.64% -12.29% -9.03% -8.21%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -19 -18 -16 -14 -8.60 -12 -7.22 -10 -9.32 -11 -8.91
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -20 -19 -17 -15 -9.17 -12 -7.52 -10 -9.43 -11 -9.00
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 4.89 0.87 0.65 0.36 0.50 0.56 0.46 0.57 0.59 1.50 2.30
Price to Tangible Book Value (P/TBV)		 4.89 0.87 0.65 0.36 0.50 0.56 0.46 0.57 0.59 1.50 2.30
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.06 -1.07 -1.07 -1.07 -1.08 -1.07 -1.05 -1.07 -1.10 -1.06 -1.04
Leverage Ratio		 1.10 1.10 1.11 1.11 1.12 1.10 1.10 1.11 1.14 1.09 1.09
Compound Leverage Factor		 0.94 1.00 1.01 1.01 0.98 1.02 0.99 1.04 1.07 1.03 1.00
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 24.99 4.02 2.00 -0.33 -0.03 -0.22 -0.72 -1.27 -2.84 9.58 14.47
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 10.91 10.61 9.75 8.43 8.68 9.67 9.33 6.87 15.73 14.32
Quick Ratio		 0.00 10.71 10.32 9.33 8.17 8.37 9.01 9.03 6.65 15.33 14.04
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -7.29 -11 -12 -15 -9.02 -10 -8.86 -8.02 -6.36 -9.07 -4.67
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -9.79 -7.52 -6.19 -5.75 -6.79 -5.21 -2.38 -4.76 -6.95 -3.53 -3.94
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 -5.88 -1.52 1.31 5.45 3.00 2.31 3.81 0.99 -0.16 1.68 -1.56
Enterprise Value (EV)		 475 -21 -40 -61 -47 -38 -39 -30 -29 38 94
Market Capitalization		 609 97 64 32 41 41 32 35 31 123 174
Book Value per Share		 $4.19 $3.72 $3.30 $2.94 $2.74 $2.44 $2.28 $2.21 $1.94 $2.27 $2.11
Tangible Book Value per Share		 $4.19 $3.72 $3.30 $2.94 $2.74 $2.44 $2.28 $2.21 $1.94 $2.27 $2.11
Total Capital		 125 111 98 88 82 73 69 60 53 82 76
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -134 -118 -105 -93 -89 -79 -71 -65 -60 -85 -80
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 3.21 -8.56 -7.23 -5.75 -7.59 -5.52 -2.38 -4.76 -6.78 -3.36 -3.98
Debt-free Net Working Capital (DFNWC)		 111 106 97 88 76 62 61 57 51 82 74
Net Working Capital (NWC)		 111 106 97 88 76 62 61 57 51 82 74
Net Nonoperating Expense (NNE)		 3.73 3.81 3.32 2.94 1.50 2.57 1.41 2.33 2.19 2.64 1.95
Net Nonoperating Obligations (NNO)		 -134 -118 -105 -93 -89 -79 -71 -65 -60 -85 -80
Total Depreciation and Amortization (D&A)		 -1.31 -1.09 -0.89 -0.73 -0.57 -0.44 -0.30 -0.21 -0.12 -0.08 -0.09
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.49) ($0.56) ($0.48) ($0.43) ($0.25) ($0.35) ($0.21) ($0.31) ($0.29) ($0.29) ($0.18)
Adjusted Weighted Average Basic Shares Outstanding		 23.60M 29.76M 29.82M 29.84M 29.83M 30.05M 30.17M 30.28M 30.22M 34.06M 44.76M
Adjusted Diluted Earnings per Share		 ($0.49) ($0.56) ($0.48) ($0.43) ($0.25) ($0.35) ($0.21) ($0.31) ($0.29) ($0.29) ($0.18)
Adjusted Weighted Average Diluted Shares Outstanding		 23.60M 29.76M 29.82M 29.84M 29.83M 30.05M 30.17M 30.28M 30.22M 34.06M 44.76M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 29.77M 29.83M 29.84M 29.88M 30.10M 30.18M 27.33M 27.40M 35.94M 36.02M 37.74M
Normalized Net Operating Profit after Tax (NOPAT)		 -13 -13 -11 -8.24 -6.02 -8.08 -5.05 -7.03 -6.52 -7.39 -6.23
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Note: The supplied filings identify the company as AN2 Therapeutics, Inc. (NASDAQ: ANTX), not Anthem. The analysis below is based on the financial data provided.

ANTX remains a development-stage biotechnology company with no reported revenue in any of the supplied quarterly income statements. Its financial profile is therefore driven by research spending, investment income, equity financing and cash consumption rather than operating sales.

The company’s quarterly losses have generally improved from 2024 levels. Net losses attributable to common shareholders declined from $16.8 million in Q1 2024 to $8.2 million in Q2 2026. The latest quarter also showed lower operating expenses of $8.9 million, compared with $10.6 million in Q1 2026 and $15.9 million in Q2 2024. However, the business remains unprofitable, and investment income continues to offset only a portion of operating costs.

Liquidity remains the most important balance-sheet consideration. At June 30, 2026, ANTX held approximately $44.3 million in cash, $34.1 million in short-term investments and $1.5 million in long-term investments. Operating cash outflow was $7.0 million in Q2 2026, down from $12.1 million in Q1 2026. At the recent quarterly burn rate, the company appears to have meaningful liquidity, although future clinical spending and financing needs could materially change its cash runway.

  • Quarterly losses are narrowing: The Q2 2026 net loss of $8.2 million was the company’s smallest reported loss among the recent periods provided, improving from $10.1 million in Q1 2026 and $14.5 million in Q2 2024.
  • Operating expenses have declined: Total operating expenses fell to $8.9 million in Q2 2026 from $10.6 million in Q1 2026 and $15.9 million in Q2 2024, suggesting tighter cost control.
  • Cash burn improved sequentially: Net cash used in operating activities decreased to $7.0 million in Q2 2026 from $12.1 million in Q1 2026 and $10.6 million in Q1 2025.
  • Liquidity remains substantial relative to quarterly losses: Cash and investments totaled roughly $79.9 million at the end of Q2 2026, providing financial flexibility for ongoing development activities.
  • Investment income provides partial support: Interest and investment income was $720,000 in Q2 2026, but this remains small compared with the company’s $8.9 million in quarterly operating expenses.
  • Investment balances are actively managed: The company has regularly purchased and sold investment securities, creating significant quarter-to-quarter swings in investing cash flow that do not represent operating growth.
  • Revenue remains absent: The company reported $0 of revenue in every supplied income statement, leaving it dependent on its cash reserves, investment income and external financing.
  • Shareholder dilution is a major risk: Weighted-average basic shares increased from approximately 29.8 million in Q2 2024 to 44.8 million in Q2 2026. Recent financing activity, including a large equity issuance in Q1 2026, indicates that additional capital may come at the expense of existing shareholders.
  • Retained earnings remain deeply negative: Retained earnings reached a deficit of $259.2 million at June 30, 2026, reflecting the company’s cumulative history of losses.
  • Assets and equity have contracted over the longer period: Total assets declined from $121.3 million in Q1 2024 to $81.7 million in Q2 2026, while total equity fell from $110.6 million to $75.9 million despite subsequent equity financing.

Overall, the statements show improving cost control and a lower quarterly cash burn, but ANTX still has no operating revenue and continues to depend on its liquidity and capital markets. For investors, the key issues to monitor are clinical progress, whether research spending rises again, the pace of cash depletion and the extent of future equity dilution.

10/10/26 05:34 AM ETAI Generated. May Contain Errors.

Anthem Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Anthem's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Anthem's net income appears to be on a downward trend, with a most recent value of -$35.17 million in 2025, falling from -$21.54 million in 2021. The previous period was -$51.32 million in 2024. Check out Anthem's forecast to explore projected trends and price targets.

Anthem's total operating income in 2025 was -$38.11 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $38.11 million

Over the last 4 years, Anthem's total revenue changed from $0.00 in 2021 to $0.00 in 2025, a change of 0.0%.

In the past 11 quarters, Anthem's cash and equivalents has ranged from $18.00 million in Q3 2025 to $53.49 million in Q1 2026, and is currently $44.32 million as of their latest financial filing in Q2 2026.

Anthem had total debt of $0.00 at the end of 2025, compared with none in 2024, and none in 2021.

Over the last 4 years, Anthem's book value per share changed from -17.97 in 2021 to 1.94 in 2025.


Related Companies

Financial statements for NASDAQ:ANTX last updated on 8/11/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Federal Reserve Reveals Disturbing New Plan To Control Your Money
A Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's vis...
Weiss Ratings | Sponsoredtc pixel
A Simple Guide to Options Trading While It's Still Free
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
My next big call (under $1)
On the first day of October, one of the biggest banks in the world changed its mind about Bitcoin. Citigroup r...
Crypto 101 Media | Sponsoredtc pixel
This free guide explains options the way they should be taught
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
A simple options setup that cuts through the noise
Ian Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...
TradeWins | Sponsoredtc pixel